Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

PaperCitations, authors & open-access status

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 130 citations, 2014 year and closed oa status.

130
Citations
2014
Year
closed
OA Status

Related on ScholarIQ

Victor Cohen
Author
The Lancet Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Diagnosis and Treatment
Topic
470M+ articles · free account